Quince Therapeutics Inc. (QNCX)
NASDAQ: QNCX
· Real-Time Price · USD
1.70
0.02 (1.19%)
At close: Aug 15, 2025, 3:59 PM
1.62
-4.71%
After-hours: Aug 15, 2025, 07:43 PM EDT
Quince Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 16.83M | 7.77M | 6.21M | 2.67M | 7.89M | 21.81M | 20.75M | 21.63M | 22.65M | 46.71M | 44.58M | 31.81M | 46.93M | 67.56M | 69.72M | 62.21M | 74.05M | 85.31M |
Short-Term Investments | 17.88M | 23.83M | 34.57M | 45.17M | 51.55M | 46.01M | 54.31M | 61.59M | 64.92M | 43.49M | 45.6M | 62.53M | 47.74M | 23.96M | 37.08M | 52.2M | 55.9M | 61.72M |
Long-Term Investments | n/a | 78K | 78K | 78K | 78K | 78K | 78K | 78K | 78K | 545K | 3.58M | 5M | 11.03M | 19.18M | 19.93M | 26.14M | 23.52M | 23.72M |
Other Long-Term Assets | 11.22M | 9.88M | 9.51M | 9.43M | 8.72M | 8.47M | 8.47M | 82K | 94K | 105K | 3.58M | 17K | 47K | 29K | 194K | 193K | 145K | 39K |
Receivables | n/a | 916K | 882K | 995K | 964K | 971K | 993K | 500K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.36M | n/a | 1.64M | 2.29M | 2.56M | 2.26M | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 2.64M | 32K | 84K | 55K | 79K | 48K | 81K | -1.26M | 143K | 1.33M | 2.37M | 2.31M | 3.58M | 4.09M | 3.39M | 495K | 438K | 557K |
Total Current Assets | 37.34M | 33.83M | 44.04M | 51.72M | 63.44M | 70.44M | 77.44M | 85.17M | 88.55M | 92.49M | 93.75M | 98.28M | 99.37M | 96.35M | 111.67M | 119.43M | 135.84M | 149.88M |
Property-Plant & Equipment | 1.08M | 941K | 813K | 767K | 800K | 810K | 619K | 53K | 116K | 177K | 684K | 583K | 692K | 573K | 1.43M | 1.66M | 1.89M | 878K |
Goodwill & Intangibles | 67.57M | 62.36M | 60.05M | 64.53M | 61.79M | 79.5M | 81.3M | n/a | n/a | n/a | 5.9M | 5.9M | 6.72M | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 79.86M | 73.26M | 70.44M | 74.8M | 71.39M | 88.85M | 102.76M | 213K | 288K | 827K | 10.16M | 11.5M | 18.49M | 19.78M | 21.55M | 27.99M | 25.55M | 24.64M |
Total Assets | 117.21M | 107.09M | 114.48M | 126.52M | 134.83M | 159.29M | 180.2M | 85.39M | 88.84M | 93.32M | 103.91M | 109.78M | 117.86M | 116.13M | 133.23M | 147.42M | 161.39M | 174.52M |
Account Payables | 1.76M | 3.01M | 2.9M | 1.62M | 2.4M | 2.07M | 2.03M | 409K | 353K | 1.65M | 570K | 1.18M | 1.87M | 3.73M | 4.91M | 2.88M | 7.19M | 2.85M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.63M | 1.37M | n/a | n/a | n/a | n/a | n/a | 8.39M | -737K | -699K | -197K |
Short-Term Debt | n/a | 102K | 96K | 101K | 94K | 93K | 64K | 61K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 7.47M | 131K | 212K | 97K | 5.88M | 6.21M | 5.07M | -1.54M | 83K | 738K | 916K | 2.59M | 182K | 121K | 180K | 8.48M | 722K | 13.56M |
Total Current Liabilities | 7.47M | 8.36M | 7.28M | 5.42M | 10.32M | 9.84M | 9.57M | 2.25M | 1.95M | 3.12M | 3.07M | 4.95M | 5.95M | 9.71M | 14.22M | 14.15M | 18.54M | 17.87M |
Long-Term Debt | 17.38M | 15.27M | 14.32M | 14.9M | 13.83M | 13.52M | 13.43M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 75.04M | 59.33M | 57.38M | 55.43M | 58.08M | 56.1M | 54.19M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 98.01M | 80.15M | 77.05M | 76.16M | 77.54M | 75.28M | 85.55M | n/a | n/a | 1.65M | 248K | 301K | 381K | 40K | 420K | 610K | 773K | 171K |
Total Liabilities | 105.47M | 88.51M | 84.33M | 81.59M | 87.86M | 85.11M | 95.12M | 2.25M | 1.95M | 3.12M | 3.32M | 5.25M | 6.33M | 9.75M | 14.64M | 14.76M | 19.31M | 18.04M |
Total Debt | 17.38M | 15.75M | 14.81M | 15.45M | 14.38M | 14.09M | 13.81M | 61K | 147K | 269K | 453K | 420K | 524K | 339K | 1.16M | 610K | 773K | 171K |
Common Stock | 53K | 44K | 44K | 43K | 43K | 43K | 43K | 36K | 36K | 36K | 36K | 36K | 36K | 30K | 30K | 30K | 30K | 29K |
Retained Earnings | -407.55M | -391.5M | -376.47M | -364.01M | -358.52M | -330.79M | -319.64M | -310.75M | -305.4M | -300.51M | -288.26M | -282.73M | -274.8M | -258.24M | -236.6M | -213.2M | -191.49M | -169.74M |
Comprehensive Income | 6.16M | 1.96M | -35K | 3.42M | 1.09M | 1.82M | 3.05M | 516K | 257K | 38K | -289K | -253K | -466K | -506K | -79K | 71K | 117K | 189K |
Shareholders Equity | 11.74M | 18.58M | 30.15M | 44.93M | 46.97M | 74.18M | 85.08M | 83.13M | 86.88M | 90.2M | 100.59M | 104.53M | 111.53M | 106.38M | 118.59M | 132.65M | 142.08M | 156.48M |
Total Investments | n/a | 23.91M | 34.65M | 45.17M | 51.63M | 46.09M | 54.38M | 61.67M | 64.92M | 43.96M | 49.18M | 67.53M | 58.77M | 43.13M | 57.01M | 78.35M | 79.42M | 85.44M |